Multibagger Penny Stock Under Rs 25: Life Sciences and Support Services Business Share Price Locked in the 5% Upper Circuit on November 10

DSIJ Intelligence-2 / 10 Nov 2025/ Categories: Mindshare, Multibaggers, Penny Stocks, Trending

Multibagger Penny Stock Under Rs 25: Life Sciences and Support Services Business Share Price Locked in the 5% Upper Circuit on November 10

The stock price has given multibagger returns of 264 per cent from its 52-week low of Rs 6.51 per share.

On Monday, the shares of TAKE Solutions Ltd rose 5 per cent to Rs 23.74 per share from its previous closing of Rs 22.61 per share. The stock’s 52-week high is Rs 25.05 per share, while its 52-week low is Rs 6.51 per share. The company recorded a traded volume of 3.31 lakh shares on the exchange.

Incorporated in 2000, TAKE Solutions Ltd is engaged in the Life Sciences and Support Services business. The company focuses on providing end-to-end services in clinical development and supply chain management. Singapore-based TAKE Solutions Pte Ltd holds a 52.90 per cent stake in the company, serving as its holding entity. TAKE Solutions Ltd operates across areas such as clinical trials, generics support, bio-availability and bioequivalence studies, regulatory filings, and pharmacovigilance, supporting the complete lifecycle of pharmaceutical and healthcare research operations.

Business Segments

  • Life Sciences Services: Full-service contract research organization (CRO) offerings, including clinical research, regulatory affairs, generics development, and pharmacovigilance.​
  • Supply Chain Management: Engineering services, product re-engineering, supply chain collaboration, and niche solutions via subsidiaries.​
  • Proprietary technologies like the "OneClinical" suite and software product "PharmaReady" cater to life sciences clients, enhancing the robustness of digital solutions for regulatory compliance and data management.​

The company's financial trajectory over the past decade has been turbulent. In Q2 FY2026, TAKE Solutions reported a profit of Rs 6.29 crore, primarily driven by gains from discontinued operations—core operations generated no revenue and posted a loss of Rs 0.62 crore for the same period. For Q1 FY2026, revenue was only Rs 0.04 crore, marking severe contraction in operating activities. Total assets have drastically dropped from Rs 2,464.45 crore (March 2020) to Rs 36.48 crore (March 2025), evidencing sharp downsizing and divestment.​

The stock price has given multibagger returns of 264 per cent from its 52-week low of Rs 6.51 per share.

Disclaimer: The article is for informational purposes only and not investment advice.